Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity


The reprogramming of differentiated cells to pluripotent cells (induced pluripotent stem (iPS) cells) is known to be an inefficient process. We recently reported that cells with short telomeres cannot be reprogrammed to iPS cells despite their normal proliferation rates1,2, probably reflecting the existence of ‘reprogramming barriers’ that abort the reprogramming of cells with uncapped telomeres. Here we show that p53 (also known as Trp53 in mice and TP53 in humans) is critically involved in preventing the reprogramming of cells carrying various types of DNA damage, including short telomeres, DNA repair deficiencies, or exogenously inflicted DNA damage. Reprogramming in the presence of pre-existing, but tolerated, DNA damage is aborted by the activation of a DNA damage response and p53-dependent apoptosis. Abrogation of p53 allows efficient reprogramming in the face of DNA damage and the generation of iPS cells carrying persistent DNA damage and chromosomal aberrations. These observations indicate that during reprogramming cells increase their intolerance to different types of DNA damage and that p53 is critical in preventing the generation of human and mouse pluripotent cells from suboptimal parental cells.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: p53 -deficiency allows reprogramming of MEFs with short telomeres.
Figure 2: p53 -deficiency abrogates apoptosis at the onset of iPS cell formation.
Figure 3: DDR activation during reprogramming.
Figure 4: p53 -null iPS cells show chromosomal instability.


  1. 1

    Marion, R. M. et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141–154 (2009)

    CAS  Article  Google Scholar 

  2. 2

    Davy, P. & Allsopp, R. Balancing out the ends during iPSC nuclear reprogramming. Cell Stem Cell 4, 95–96 (2009)

    CAS  Article  Google Scholar 

  3. 3

    Jaenisch, R. & Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567–582 (2008)

    CAS  Article  Google Scholar 

  4. 4

    Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006)

    CAS  Article  Google Scholar 

  5. 5

    Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007)

    CAS  Article  Google Scholar 

  6. 6

    Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318–324 (2007)

    ADS  CAS  Article  Google Scholar 

  7. 7

    Wernig, M., Meissner, A., Cassady, J. P. & Jaenisch, R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2, 10–12 (2008)

    CAS  Article  Google Scholar 

  8. 8

    Stadtfeld, M., Maherali, N., Breault, D. T. & Hochedlinger, K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2, 230–240 (2008)

    CAS  Article  Google Scholar 

  9. 9

    Meissner, A., Wernig, M. & Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nature Biotechnol. 25, 1177–1181 (2007)

    CAS  Article  Google Scholar 

  10. 10

    Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnol. 26, 101–106 (2008)

    CAS  Article  Google Scholar 

  11. 11

    Kim, J. B. et al. Oct4-induced pluripotency in adult neural stem cells. Cell 136, 411–419 (2009)

    CAS  Article  Google Scholar 

  12. 12

    Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34 (1997)

    CAS  Article  Google Scholar 

  13. 13

    Collado, M., Blasco, M. A. & Serrano, M. Cellular senescence in cancer and aging. Cell 130, 223–233 (2007)

    CAS  Article  Google Scholar 

  14. 14

    Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999)

    CAS  Article  Google Scholar 

  15. 15

    Vousden, K. H. & Lane, D. P. p53 in health and disease. Nature Rev. Mol. Cell Biol. 8, 275–283 (2007)

    CAS  Article  Google Scholar 

  16. 16

    Toledo, L. I., Murga, M., Gutierrez-Martinez, P., Soria, R. & Fernandez-Capetillo, O. ATR signaling can drive cells into senescence in the absence of DNA breaks. Genes Dev. 22, 297–302 (2008)

    CAS  Article  Google Scholar 

  17. 17

    Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499–506 (2003)

    ADS  CAS  Article  Google Scholar 

  18. 18

    Xu, Y. et al. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10, 2411–2422 (1996)

    CAS  Article  Google Scholar 

  19. 19

    Ward, I. M., Minn, K., van Deursen, J. & Chen, J. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol. Cell. Biol. 23, 2556–2563 (2003)

    CAS  Article  Google Scholar 

  20. 20

    Zhao, Y. et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3, 475–479 (2008)

    CAS  Article  Google Scholar 

  21. 21

    Hochedlinger, K., Yamada, Y., Beard, C. & Jaenisch, R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121, 465–477 (2005)

    CAS  Article  Google Scholar 

  22. 22

    Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864–870 (2005)

    ADS  CAS  Article  Google Scholar 

  23. 23

    Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638–642 (2006)

    ADS  CAS  Article  Google Scholar 

  24. 24

    Herrera, E. et al. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18, 2950–2960 (1999)

    CAS  Article  Google Scholar 

  25. 25

    Barlow, C. et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159–171 (1996)

    CAS  Article  Google Scholar 

  26. 26

    Blelloch, R., Venere, M., Yen, J. & Ramalho-Santos, M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 1, 245–247 (2007)

    CAS  Article  Google Scholar 

  27. 27

    Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008)

    ADS  CAS  Article  Google Scholar 

  28. 28

    Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34 (1997)

    CAS  Article  Google Scholar 

  29. 29

    Samper, E., Goytisolo, F. A., Slijepcevic, P., van Buul, P. P. & Blasco, M. A. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 1, 244–252 (2000)

    CAS  Article  Google Scholar 

  30. 30

    Zijlmans, J. M. et al. Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc. Natl Acad. Sci. USA 94, 7423–7428 (1997)

    ADS  CAS  Article  Google Scholar 

Download references


We thank R. Serrano for mouse colony management, and M. Cañamero and the Comparative Pathology Unit at the CNIO for teratoma analysis. K.S. is recipient of a contract from the Spanish Association Against Cancer (AECC). Work in the laboratory of M.A.B. is funded by grants from the MICINN (CONSOLIDER), the Regional Government of Madrid, the European Union, the European Research Council (ERC), the AECC, and the Korber European Research Award.

Author Contributions R.M.M. and K.S. performed most of the experimental work. H.L., M.M., R.B. and S.O. made critical experimental contributions. R.M.M., K.S., O.F.-C., M.S. and M.A.B. designed the experimental plan, analysed and interpreted the data. M.A.B. directed the project and wrote the paper.

Author information



Corresponding author

Correspondence to Maria A. Blasco.

Supplementary information

Supplementary Information

This file contains Supplementary Figures S1-S4 with Legends and Supplementary Tables 1-2. (PDF 2714 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Marión, R., Strati, K., Li, H. et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149–1153 (2009).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing